Port Wine Stain Clinical Trial
Official title:
Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks
Port wine stain is a congenital, progressive vascular malformation of skin involving post-capillary venules that occurs in an estimated 4 children per 1,000 live births. Approximately 1,200,000 individuals in the United States and twenty-six million people worldwide have Port wine stain birthmarks. Since most of the malformations occur on the face, Port wine stain is a clinically significant problem in the majority of patients. Port wine stain should not be considered a cosmetic problem but a disease with potentially devastating psychological and physical complications. Personality development is adversely influenced in virtually all patients by the negative reaction of others to a "marked" person. Port wine stain are initially flat red macules, but lesions tend to darken progressively to purple, and by middle age, often become raised as a result of the development of vascular nodules. Hypertrophy of underlying soft tissue further disfigures the facial features of many patients.
The researcher can use alexandrite and pulsed dye lasers pulses combined delivery to improve port wine stain blanching. The alexandrite and pulsed dye lasers are both approved by the Food and Drug Administration for the treatment of Port wine stain. However, the degree of port wine stain blanching seen following either alexandrite or pulsed dye lasers treatment remains variable and unpredictable. Treatment of port wine stains can use either alexandrite or pulsed dye alone and with the combined delivery of alexandrite and pulsed dye lasers pulses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01438047 -
Optical Frequency Domain Imaging (OFDI) in Dermatology
|
N/A | |
| Terminated |
NCT00782483 -
Personalized Interactive Laser Therapy of Port Wine Stain
|
N/A | |
| Completed |
NCT03948997 -
The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains
|
N/A | |
| Completed |
NCT01364857 -
French National Cohort of Children With Port Wine Stain
|
N/A | |
| Withdrawn |
NCT00969397 -
Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks
|
Phase 1/Phase 2 | |
| Completed |
NCT00800722 -
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
|
Phase 1 | |
| Completed |
NCT00585247 -
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
|
N/A | |
| Active, not recruiting |
NCT00247299 -
Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform
|
N/A | |
| Completed |
NCT00580736 -
Optical Clearing of the Skin in Conjunction With Laser Treatments
|
Phase 1 | |
| Completed |
NCT00540566 -
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
|
||
| Withdrawn |
NCT02035319 -
Effect of Laser Treatment on Capillary Malformations
|
N/A | |
| Withdrawn |
NCT01166919 -
Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks
|
Phase 1 | |
| Completed |
NCT00830466 -
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
|
Phase 1 | |
| Completed |
NCT00540371 -
Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
|
||
| Completed |
NCT01333553 -
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
|